Trials / Unknown
UnknownNCT03847623
Effect of Preoperative Curcumin in Breast Cancer Patients
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- University of Malaya · Academic / Other
- Sex
- Female
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Effect of curcumin on modulation of immune and inflammatory parameters in pre-operative patients
Detailed description
Patients diagnosed with breast cancer will be supplemented with either curcumin or placebo for a minimum period of 2 weeks and may be extended up to 4 weeks prior to their surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Curcumin | Natural compound, active ingredient of turmeric, in bi-daily dosing |
| OTHER | Placebo | Placebo tablets at bi-daily dosing |
Timeline
- Start date
- 2017-06-18
- Primary completion
- 2020-12-31
- Completion
- 2020-12-31
- First posted
- 2019-02-20
- Last updated
- 2020-03-25
Locations
1 site across 1 country: Malaysia
Source: ClinicalTrials.gov record NCT03847623. Inclusion in this directory is not an endorsement.